Placebo for Tezepelumab
Phase 2
Placebo for Tezepelumab is one of 2 therapeutic programs targeting Peanut Allergy. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
2 competitors in Peanut Allergy
#DrugCompanyPhaseTrials
1Tezspire
AstraZenecaPhase 2
Placebo for Tezepelumab
NNational Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Peanut Allergy1 trial
Efficacy of Tezepelumab in Peanut Oral Immunotherapy: a Double-Blind, Randomized, Placebo-Controlled Trial
Recruiting·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT07015996·62 enrolled
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Placebo for Tezepelumab. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 2[1]